Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Senior

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Nature Biotechnology|November 7, 2015
UK funding agencies weigh in on human germline editingMelanie Senior
Nature Biotechnology|July 2, 2020
The biopharmaceutical anomalyMelanie Senior
Nature Biotechnology|April 9, 2020
Europe's biotech renaissanceMelanie Senior
Nature Biotechnology|January 10, 2015
Foundation receives $3.3-billion windfall for KalydecoMelanie Senior
Nature Reviews. Drug Discovery|October 2, 2015
Heart drug pushes outcome-based pricing plansMelanie Senior
Nature Biotechnology|June 7, 2018
Beating the organ clockMelanie Senior
Nature Biotechnology|March 26, 2022
Innovators take cover as market bubble burstsMelanie Senior
Nature Biotechnology|March 10, 2015
First US biosimilar edges towards marketMelanie Senior
Nature Biotechnology|March 31, 2023
Precision financingMelanie Senior
Nature Biotechnology|November 7, 2019
Deerfield builds NYC campus to support life sciences startupsMelanie Senior
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Nature Biotechnology|November 7, 2015
UK funding agencies weigh in on human germline editingMelanie Senior
Nature Biotechnology|July 2, 2020
The biopharmaceutical anomalyMelanie Senior
Nature Biotechnology|April 9, 2020
Europe's biotech renaissanceMelanie Senior
Nature Biotechnology|January 10, 2015
Foundation receives $3.3-billion windfall for KalydecoMelanie Senior
Nature Reviews. Drug Discovery|October 2, 2015
Heart drug pushes outcome-based pricing plansMelanie Senior
Nature Biotechnology|June 7, 2018
Beating the organ clockMelanie Senior
Nature Biotechnology|March 26, 2022
Innovators take cover as market bubble burstsMelanie Senior
Nature Biotechnology|March 10, 2015
First US biosimilar edges towards marketMelanie Senior
Nature Biotechnology|March 31, 2023
Precision financingMelanie Senior
Nature Biotechnology|November 7, 2019
Deerfield builds NYC campus to support life sciences startupsMelanie Senior
Pageof 6